With the cooperation of EP Bio Partners, who always handle administrative duties for the Red Dragon Conferences, and our co-presenter Tanakaya Bio Communications, we held the 32nd Red Dragon Conference on Friday, September 12, 2025, at EPS in Iidabashi, Tokyo.
[Program for the 32nd Red Dragon Conference]
- China Development & Regulatory Information UPDATE – CDE’s Drug Review Annual Report (2024), Annual Report on Progress of Clinical Trials for New Drug Registration in China (2024), CDE-initiated Pilot Program on the patient-Centered Action for Rare diseases Encouragement (CARE Program), etc.
Speaker: Yumiko Kobayashi, Former Daiichi Sankyo (Tanakaya Bio Communications Co., Ltd.)
- Japan and China Development & Regulatory Information UPDATE – Measures to Eliminate Drug Lag and Drug Loss in Japan, and Japan’s Initiatives to Contribute to the Business Expansion of Chinese Companies into Japan (Information Dissemination to China, Reactions from Chinese Companies), etc.
Speaker: Tetsuomi Takano, Chairperson of the Red Dragon Conference (President & CEO, t2T Healthcae Inc.)
